Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
261
-
Total 13F shares, excl. options
-
65.9M
-
Shares change
-
-1.51M
-
Total reported value, excl. options
-
$3.25B
-
Value change
-
-$65.5M
-
Put/Call ratio
-
1.1
-
Number of buys
-
114
-
Number of sells
-
-165
-
Price
-
$49.41
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q1 2019
338 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q1 2019.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 261 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.9M shares
of 115M outstanding shares and own 57.18% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.54M shares), VANGUARD GROUP INC (7.15M shares), WELLINGTON MANAGEMENT GROUP LLP (5.12M shares), JANUS HENDERSON GROUP PLC (3.38M shares), STATE STREET CORP (2.56M shares), AQR CAPITAL MANAGEMENT LLC (2.21M shares), Investec Asset Management LTD (1.38M shares), RENAISSANCE TECHNOLOGIES LLC (1.36M shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (1.34M shares), and Van Berkom & Associates Inc. (1.34M shares).
This table shows the top 261 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.